409 related articles for article (PubMed ID: 31617130)
1. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.
Wang JH; Ou HY; Yen YH; Hung CH; Lu SN
Liver Int; 2023 Sep; 43(9):1901-1908. PubMed ID: 37249034
[TBL] [Abstract][Full Text] [Related]
3. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
[TBL] [Abstract][Full Text] [Related]
4. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
[TBL] [Abstract][Full Text] [Related]
5. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
[TBL] [Abstract][Full Text] [Related]
6. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
[TBL] [Abstract][Full Text] [Related]
8. Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting.
Ahn SB; Jun DW; Kang BK; Kim M; Chang M; Nam E
Medicine (Baltimore); 2018 Dec; 97(50):e13636. PubMed ID: 30558054
[TBL] [Abstract][Full Text] [Related]
9. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
[TBL] [Abstract][Full Text] [Related]
12. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease.
Shao CX; Ye J; Dong Z; Li F; Lin Y; Liao B; Feng S; Zhong B
Ther Adv Chronic Dis; 2021; 12():20406223211033119. PubMed ID: 34408822
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
Gu J; Liu S; Du S; Zhang Q; Xiao J; Dong Q; Xin Y
Eur Radiol; 2019 Jul; 29(7):3564-3573. PubMed ID: 30899974
[TBL] [Abstract][Full Text] [Related]
15. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
Jung J; Han A; Madamba E; Bettencourt R; Loomba RR; Boehringer AS; Andre MP; Erdman JW; O'Brien WD; Fowler KJ; Sirlin CB; Loomba R
Radiology; 2022 Jul; 304(1):75-82. PubMed ID: 35348378
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
Bao J; Lv Y; Wang K; Wang Q; Chen Y; Dong Y; Zhu Y; Wang W
J Ultrasound Med; 2023 Jul; 42(7):1481-1489. PubMed ID: 36583414
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
[TBL] [Abstract][Full Text] [Related]
19. Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard.
Ajmera VH; Cachay ER; Ramers CB; Bassirian S; Singh S; Bettencourt R; Richards L; Hamilton G; Middleton M; Fowler K; Sirlin C; Loomba R
Clin Infect Dis; 2021 Jun; 72(12):2124-2131. PubMed ID: 32975278
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantation.
Zhuang RH; Weinstock AK; Ganesh S; Behari J; Malik SM; Bataller R; Furlan A; Hughes CB; Humar A; Duarte-Rojo A
Clin Transplant; 2022 Nov; 36(11):e14786. PubMed ID: 35993599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
